Serina Therapeutics(SER.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Serina Therapeutics
SER.US
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson’s disease that is in preclinical stage development; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214 a POZ conjugate of rotigotine for the treatment of early Parkinson’s and Restless Leg Syndrome, which has completed phase 1a clinical trial. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases.
1.880 T
SER.USMarket value -Rank by Market Cap -/-

Financial Score

18/01/2026 Update
D
BiotechnologyIndustry
Industry Ranking303/398
Industry medianC
Industry averageD
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE221.81%A
    • Profit Margin-16022.41%E
    • Gross Margin0.00%E
  • Growth ScoreD
    • Revenue YoY-96.33%E
    • Net Profit YoY-155.82%E
    • Total Assets YoY66.95%A
    • Net Assets YoY111.53%A
  • Cash ScoreE
    • Cash Flow Margin-0.62%D
    • OCF YoY-96.33%E
  • Operating ScoreE
    • Turnover0.01E
  • Debt ScoreE
    • Gearing Ratio87.16%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    12 Health Care Stocks Moving In Thursday's After-Market Session

    In Thursday's after-market session, several health care stocks experienced notable movements. Gainers included Serina Therapeutics (up 8.9% to $3.07), OneMedNet (up 8.21% to $0.92), and ALPS Group (up 6.0% to $1.06). Conversely, Gelteq saw a decline of 8.9% to $1.13, while Pheton Holdings dropped 5.3% to $0.85. Other notable losers included Inspire Veterinary (down 4.91% to $0.05) and CNS Pharma (down 3.4% to $7.12).

    benzinga_article·
    US
    ONMD
    +5.89%
    US
    SER
    +15.24%
    US
    ALPS
    -1.00%
    benzinga_article·
    US
    ONMD
    +5.89%
    US
    SER
    +15.24%
    US
    ALPS
    -1.00%

    Serina Therapeutics Faces NYSE Delisting Risk Over Shareholders' Equity Deficiency

    Serina Therapeutics Inc. faces delisting risk from the NYSE due to a deficiency in stockholders' equity, which dropped to $1.6 million as of September 30, 2025. The company has reported losses in three of its last four fiscal years, failing to meet the NYSE's continued listing criteria. Serina must submit a compliance plan by February 8, 2026, to regain compliance by July 9, 2027, or face potential delisting proceedings.

    Reuters·
    US
    SER
    +15.24%
    Reuters·
    US
    SER
    +15.24%

    10% Owner Randy Soule Reports Disposal of XCF Global Inc. Common Shares

    Randy Soule, a 10% owner of XCF Global Inc., has reported the disposal of common shares of the company. The full filing is available through the provided link. This news brief was generated by Public Technologies and is for informational purposes only, not to be considered as financial, investment, or legal advice.

    Reuters·
    US
    SAFX
    -2.90%
    Reuters·
    US
    SAFX
    -2.90%

    Chief Scientific Officer Randall Moreadith Reports Sale of Serina Therapeutics Inc. Common Shares

    Randall Moreadith, Chief Scientific Officer of Serina Therapeutics Inc., has reported the sale of common shares of the company. The full filing is available through the provided link. This news brief was generated by Public Technologies and is for informational purposes only, not to be considered as financial, investment, or legal advice. The original content was published by Serina Therapeutics Inc. via EDGAR on January 09, 2026.

    Reuters·
    US
    SER
    +15.24%
    Reuters·
    US
    SER
    +15.24%

    12 Health Care Stocks Moving In Wednesday's After-Market Session

    In Wednesday's after-market session, several health care stocks experienced notable movements. Gainers included Streamex (NASDAQ:STEX) with a 7.0% increase to $3.67, Aspire Biopharma Hldgs (NASDAQ:ASBP) up 5.81% to $0.13, and Serina Therapeutics (AMEX:SER) rising 4.6% to $2.5. Conversely, Immuneering (NASDAQ:IMRX) saw a significant drop of 23.8% to $6.35, followed by Erasca (NASDAQ:ERAS) down 14.12% to $4.44, and Revolution Medicines (NASDAQ:RVMD) declining 13.35% to $89.0.

    benzinga_article·
    US
    ASBP
    +6.45%
    US
    SER
    +15.24%
    benzinga_article·
    US
    ASBP
    +6.45%
    US
    SER
    +15.24%
    © 2026 Longbridge｜Disclaimer